Benjamin Toogood
Director/Board Member bij KAROLINSKA DEVELOPMENT AB
Profiel
Benjamin Toogood is currently the Chief Executive Officer & Director at invoX Pharma Ltd., Director & Vice President-Business Development at Pharmathen International SA, and Independent Director at Karolinska Development AB.
He is also a Director at Softhale NV, PHion Therapeutics Ltd., and Global Head-Business Development at Sino Biopharmaceutical Ltd.
In the past, he worked as the Global Head-Business Development at Sandoz AG and Vice President-Business Development at Pharmathen SA. Toogood has a graduate degree from the University of the Witwatersrand and an undergraduate degree from Rhodes University.
Actieve functies van Benjamin Toogood
Bedrijven | Functie | Begin |
---|---|---|
KAROLINSKA DEVELOPMENT AB | Director/Board Member | 19-02-2021 |
SINO BIOPHARMACEUTICAL LIMITED | Corporate Officer/Principal | 01-01-2021 |
Pharmathen International SA
Pharmathen International SA Pharmaceuticals: MajorHealth Technology Pharmathen was founded in 1969 in Athens, as a private pharmaceutical company, and is focused on the development and marketing of pharmaceuticals, with a strong position in generics. With 3 state of the art research laboratories and 2 manufacturing units, Pharmathen is a completely vertically integrated company and its activities extend from the development of pharmaceutical products up to their distribution. The company's human resources works in the sectors of Research & Development (R&D), production and distribution of drugs to different countries worldwide. Now, Pharmathen's products are approved in all EU markets and distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada. | Director/Board Member | 01-01-2006 |
invoX Pharma Ltd.
invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., invoX Pharma Ltd. is a British biopharmaceutical company. The private company is based in Kingston-upon-Thames, UK. The company was founded in 2021. Benjamin Toogood has been the CEO of the company since 2023. | Chief Executive Officer | 08-03-2023 |
Softhale NV
Softhale NV Miscellaneous Commercial ServicesCommercial Services Softhale NV engages in manufacturing medical, clinical and pharmaceutical equipment. The company was founded by Jurgen Rawert and Frank Bartels and is headquartered in Diepenbeek, Belgium. | Director/Board Member | - |
PHion Therapeutics Ltd.
PHion Therapeutics Ltd. BiotechnologyHealth Technology PHion Therapeutics Ltd. operates as a therapeutic vaccine development company. Its vaccine program focuses on viral infections as it evokes a strong interferon gamma response. The firm's technology are RAVA and RAVA-V. The company was founded by Helen McCarthy in 2017 and is headquartered in Belfast, the United Kingdom. | Director/Board Member | - |
Eerdere bekende functies van Benjamin Toogood
Bedrijven | Functie | Einde |
---|---|---|
Pharmathen SA
Pharmathen SA Pharmaceuticals: MajorHealth Technology Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece. | Corporate Officer/Principal | - |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Corporate Officer/Principal | - |
Opleiding van Benjamin Toogood
University of the Witwatersrand | Graduate Degree |
Rhodes University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
SINO BIOPHARMACEUTICAL LIMITED | Health Technology |
KAROLINSKA DEVELOPMENT AB | Finance |
Bedrijven in privébezit | 6 |
---|---|
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Health Technology |
Pharmathen SA
Pharmathen SA Pharmaceuticals: MajorHealth Technology Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece. | Health Technology |
Pharmathen International SA
Pharmathen International SA Pharmaceuticals: MajorHealth Technology Pharmathen was founded in 1969 in Athens, as a private pharmaceutical company, and is focused on the development and marketing of pharmaceuticals, with a strong position in generics. With 3 state of the art research laboratories and 2 manufacturing units, Pharmathen is a completely vertically integrated company and its activities extend from the development of pharmaceutical products up to their distribution. The company's human resources works in the sectors of Research & Development (R&D), production and distribution of drugs to different countries worldwide. Now, Pharmathen's products are approved in all EU markets and distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada. | Health Technology |
Softhale NV
Softhale NV Miscellaneous Commercial ServicesCommercial Services Softhale NV engages in manufacturing medical, clinical and pharmaceutical equipment. The company was founded by Jurgen Rawert and Frank Bartels and is headquartered in Diepenbeek, Belgium. | Commercial Services |
PHion Therapeutics Ltd.
PHion Therapeutics Ltd. BiotechnologyHealth Technology PHion Therapeutics Ltd. operates as a therapeutic vaccine development company. Its vaccine program focuses on viral infections as it evokes a strong interferon gamma response. The firm's technology are RAVA and RAVA-V. The company was founded by Helen McCarthy in 2017 and is headquartered in Belfast, the United Kingdom. | Health Technology |
invoX Pharma Ltd.
invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., invoX Pharma Ltd. is a British biopharmaceutical company. The private company is based in Kingston-upon-Thames, UK. The company was founded in 2021. Benjamin Toogood has been the CEO of the company since 2023. | Health Technology |